NYSE:A - Agilent Technologies Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$62.84 +0.05 (+0.08 %)
(As of 06/21/2018 03:37 PM ET)
Previous Close$62.83
Today's Range$62.34 - $63.21
52-Week Range$58.22 - $75.00
Volume236,826 shs
Average Volume2.74 million shs
Market Capitalization$20.32 billion
P/E Ratio26.51
Dividend Yield0.94%
Beta1.28
Agilent Technologies logoAgilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; microfluidics based automated electrophoresis products; cell analysis plate based assays; laboratory software and informatics systems; laboratory automation; dissolution testing; vacuum pumps; and measurement technologies. The Diagnostics and Genomics segment provides reagents, instruments, software, and consumables; arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression profiling, as well as sequencing target enrichment services; and equipment focused on production of synthesized oligonucleotides for use as active pharmaceutical ingredients. The Agilent CrossLab segment offers GC and LC columns, sample preparation products, custom chemistries, and various laboratory instrument supplies; and startup, operational, training, and compliance support, as well as asset management and consultation services. The company markets its products through direct sales, electronic commerce, resellers, manufacturers' representatives, and distributors. It has collaboration with the University of Southern California Michelson Center for Convergent Bioscience. Agilent Technologies, Inc. was founded in 1999 and is headquartered in Santa Clara, California.

Receive A News and Ratings via Email

Sign-up to receive the latest news and ratings for A and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Analytical instruments
Sub-IndustryLife Sciences Tools & Services
SectorComputer and Technology
SymbolNYSE:A
CUSIP00846U10
Phone408-345-8886

Debt

Debt-to-Equity Ratio0.39
Current Ratio3.32
Quick Ratio2.88

Price-To-Earnings

Trailing P/E Ratio26.51
Forward P/E Ratio23.54
P/E Growth2.22

Sales & Book Value

Annual Sales$4.47 billion
Price / Sales4.50
Cash Flow$3.0125 per share
Price / Cash20.86
Book Value$14.43 per share
Price / Book4.35

Profitability

EPS (Most Recent Fiscal Year)$2.36
Net Income$684 million
Net Margins5.02%
Return on Equity18.01%
Return on Assets9.80%

Miscellaneous

Employees13,500
Outstanding Shares319,950,000

Agilent Technologies (NYSE:A) Frequently Asked Questions

What is Agilent Technologies' stock symbol?

Agilent Technologies trades on the New York Stock Exchange (NYSE) under the ticker symbol "A."

How often does Agilent Technologies pay dividends? What is the dividend yield for Agilent Technologies?

Agilent Technologies announced a quarterly dividend on Wednesday, May 16th. Stockholders of record on Tuesday, July 3rd will be given a dividend of $0.149 per share on Wednesday, July 25th. This represents a $0.60 annualized dividend and a dividend yield of 0.94%. The ex-dividend date is Monday, July 2nd. View Agilent Technologies' Dividend History.

How were Agilent Technologies' earnings last quarter?

Agilent Technologies Inc (NYSE:A) released its quarterly earnings data on Monday, May, 14th. The medical research company reported $0.65 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.64 by $0.01. The medical research company earned $1.21 billion during the quarter, compared to analyst estimates of $1.21 billion. Agilent Technologies had a net margin of 5.02% and a return on equity of 18.01%. The business's revenue was up 9.4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.58 EPS. View Agilent Technologies' Earnings History.

When is Agilent Technologies' next earnings date?

Agilent Technologies is scheduled to release their next quarterly earnings announcement on Monday, August, 13th 2018. View Earnings Estimates for Agilent Technologies.

What guidance has Agilent Technologies issued on next quarter's earnings?

Agilent Technologies updated its FY18 earnings guidance on Monday, May, 14th. The company provided EPS guidance of $2.63-2.67 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.70. The company issued revenue guidance of $4.85-4.87 billion, compared to the consensus revenue estimate of $4.92 billion.Agilent Technologies also updated its Q3 guidance to $0.61-0.63 EPS.

What price target have analysts set for A?

12 Wall Street analysts have issued 12-month price targets for Agilent Technologies' stock. Their forecasts range from $60.73 to $91.00. On average, they expect Agilent Technologies' share price to reach $72.8108 in the next twelve months. View Analyst Ratings for Agilent Technologies.

Who are some of Agilent Technologies' key competitors?

Who are Agilent Technologies' key executives?

Agilent Technologies' management team includes the folowing people:
  • Mr. Michael R. McMullen, CEO, Pres & Director (Age 57)
  • Mr. Didier Hirsch, Sr. VP & CFO (Age 67)
  • Mr. Mark Doak, Sr. VP & Pres of Agilent CrossLab Group (Age 63)
  • Mr. Jacob Thaysen, Sr. VP and Pres of Life Sciences & Applied Markets Group (Age 43)
  • Mr. Rodney Gonsalves, Chief Accounting Officer, VP & Corp. Controller (Age 52)

Has Agilent Technologies been receiving favorable news coverage?

News headlines about A stock have trended somewhat positive this week, Accern Sentiment Analysis reports. The research firm identifies negative and positive press coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Agilent Technologies earned a media sentiment score of 0.18 on Accern's scale. They also gave news stories about the medical research company an impact score of 49.62 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the next several days.

Who are Agilent Technologies' major shareholders?

Agilent Technologies' stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (8.82%), OppenheimerFunds Inc. (1.44%), JPMorgan Chase & Co. (1.24%), Cantillon Capital Management LLC (1.20%), Northern Trust Corp (1.19%) and American Century Companies Inc. (1.09%). Company insiders that own Agilent Technologies stock include Boon Hwee Koh, Didier Hirsch, Dominique Grau, Heidi Fields, Jacob Thaysen, James Cullen, Mark Doak, Michael R Mcmullen, Patrick Kaltenbach, Paul N Clark and Rodney Gonsalves. View Institutional Ownership Trends for Agilent Technologies.

Which institutional investors are selling Agilent Technologies stock?

A stock was sold by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., Victory Capital Management Inc., Cantillon Capital Management LLC, PNC Financial Services Group Inc., State of Tennessee Treasury Department, Select Equity Group L.P., Swiss National Bank and Sei Investments Co.. Company insiders that have sold Agilent Technologies company stock in the last year include Boon Hwee Koh, Didier Hirsch, Dominique Grau, Heidi Fields, Jacob Thaysen, Mark Doak, Michael R Mcmullen, Patrick Kaltenbach and Rodney Gonsalves. View Insider Buying and Selling for Agilent Technologies.

Which institutional investors are buying Agilent Technologies stock?

A stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., OppenheimerFunds Inc., Old Mutual Global Investors UK Ltd., Royal Bank of Canada, Echo Street Capital Management LLC, Wells Fargo & Company MN, Natixis and Amundi Pioneer Asset Management Inc.. View Insider Buying and Selling for Agilent Technologies.

How do I buy shares of Agilent Technologies?

Shares of A can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Agilent Technologies' stock price today?

One share of A stock can currently be purchased for approximately $63.13.

How big of a company is Agilent Technologies?

Agilent Technologies has a market capitalization of $20.32 billion and generates $4.47 billion in revenue each year. The medical research company earns $684 million in net income (profit) each year or $2.36 on an earnings per share basis. Agilent Technologies employs 13,500 workers across the globe.

How can I contact Agilent Technologies?

Agilent Technologies' mailing address is 5301 STEVENS CREEK BLVD, SANTA CLARA CA, 95051. The medical research company can be reached via phone at 408-345-8886 or via email at [email protected]


MarketBeat Community Rating for Agilent Technologies (A)

Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  579 (Vote Outperform)
Underperform Votes:  347 (Vote Underperform)
Total Votes:  926
MarketBeat's community ratings are surveys of what our community members think about Agilent Technologies and other stocks. Vote "Outperform" if you believe A will outperform the S&P 500 over the long term. Vote "Underperform" if you believe A will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.